CD95 Ligand (CD95L) in Normal Human Lymphoid Tissues
- 1 January 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (1) , 193-201
- https://doi.org/10.1016/s0002-9440(10)65265-0
Abstract
No abstract availableKeywords
Funding Information
- Universität Ulm (P332, D.0687 STR 543/1–1)
- Deutsche Forschungsgemeinschaft (P332, D.0687 STR 543/1–1)
This publication has 41 references indexed in Scilit:
- Fas and FasL in the homeostatic regulation of immune responsesPublished by Elsevier ,2001
- Apoptosis by Death FactorCell, 1997
- Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.The Journal of cell biology, 1996
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteasesEuropean Journal of Immunology, 1995
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991